查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1990185

消化系统医疗设备市场：依产品类型、技术、应用和最终用户划分－2026-2032年全球市场预测

Gastrointestinal Devices Market by Product Type, Technology, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，胃肠道医疗设备市场价值将达到 87.6 亿美元，到 2026 年将成长至 93.9 亿美元，到 2032 年将达到 149.1 亿美元，复合年增长率为 7.89%。

主要市场统计数据
基准年 2025 87.6亿美元
预计年份：2026年 93.9亿美元
预测年份 2032 149.1亿美元
复合年增长率 (%) 7.89%

简要介绍影响胃肠医疗设备创新未来的临床因素、技术加速发展和相关人员优先事项。

胃肠医疗设备市场正处于临床需求、快速技术进步和不断演变的医疗服务模式的交汇点。近年来，诊断影像、治疗性内视镜和止血技术取得了全面进展，这些进展共同促成了更快的临床决策和更少的侵入性手术。这些趋势的驱动因素包括：对微创手术日益增长的需求、对门诊和以护理为基础的治疗方式的日益重视，以及对高解析度成像以识别细微粘膜病变的需求。因此，器械开发人员和临床团队正在尝试使用整合平台，这些平台结合了卓越的光学性能、精密的辅助器具和软体驱动的工作流程，以缩短手术时间并提高治疗精度。

对重塑竞争动态的变革性临床、技术和商业性变化进行详细分析，包括手术施行地点、医疗设备的采用以及其他因素。

胃肠医疗设备市场正经历着变革性的转变，这些变革正在改变临床路径和经营模式。在技​​术层面，高解析度成像和微型化平台使得病变早期检测成为可能，从而影响诊断演算法和治疗策略。同时，光学、机器人和软体分析的融合催生了新型混合平台，这些平台兼具诊断清晰度和精准干预能力，手术数量也正从住院患者转向门诊和日间手术患者。

全面检验2025 年美国关税将如何改变整个消化器官系统医疗设备製造商的供应链、筹资策略和产业计画。

美国2025年实施的关税政策对全球消化器官系统医疗设备製造商的供应链带来了许多不利影响，从多方面衝击了零件采购、生产策略和定价方式。与严重依赖进口零件和成品的製造商相比，拥有垂直整合供应链和国内生产能力的製造商受到的影响相对较小。因此，采购团队必须重新评估供应商多元化和近岸外包的机会，以降低关税带来的风险。

全面的细分洞察，解释了产品类型、临床应用、最终用户和技术选择如何驱动差异化的采用和定位。

细分市场分析表明，产品多样性和功能专业化是整个胃肠病学领域商业化策略和临床导入路径的核心。依产品类型分析，主要器械类别包括胶囊内视镜系统、内视镜成像系统、内视镜治疗器械和止血器械。在内视镜成像领域，高解析度内视镜、超细内视镜和影像内视镜等细分子类别针对不同的应用场景，特别是改善黏膜可视化、进入解剖结构狭窄的管腔以及整合数位化工作流程。内视镜治疗器械也呈现类似的分类，包括用于结构性介入的充气球囊、用于切除病变的息肉切除器械以及用于维持管腔通畅的支架。这些器械的选择通常取决于病灶的特征和手术目标。止血装置进一步细分为止血夹、止血粉和热凝固装置，每种装置的选择都基于出血原因、可近性和临床医生的偏好。

战略区域洞察，详细说明美洲、欧洲、中东和非洲以及亚太地区的差异如何影响设备采用、证据需求和商业性方法。

区域趋势对消化器官系统医疗设备的临床特性优先顺序、报销槓桿和市场进入策略有显着影响。在美洲，医疗服务模式的趋势包括向门诊治疗的转变、医疗系统的整合，以及对既能提高处理能力又能维持强有力临床证据的医疗设备日益增长的需求。虽然能够简化流程并与集中采购机制相契合的技术在该地区往往迅速普及，但对可靠的上市后数据和可互操作系统的需求仍然存在。

关键企业策略和竞争行动揭示了平台领导者、敏捷创新者和製造合作伙伴如何塑造市场轨迹。

消化器官系统医疗设备产业的竞争格局由成熟的平台供应商、目标明确的创新者和垂直整合的製造商组成。主要企业通常会投资于全面的临床试验项目、严格的上市后监测以及与医疗系统的合作，以证明其产品的价值。这些企业通常利用模组化平台实现分阶段升级，有助于从长期部署基地以及耗材和配件的持续收入中获利。

为製造商和供应商提供切实可行的优先建议，以加快采用速度、增强韧性，并在临床环境中实现商业性差异化。

产业领导企业应优先考虑一系列切实可行的倡议，以在整个胃肠医疗设备市场实现临床、营运和商业性价值。首先，产品开发必须与可衡量的临床结果和工作流程效率保持一致，以便采购委员会能够轻鬆量化其价值。投资产生真实世界数据 (REW)，以证明手术时间缩短、併发症率降低或诊断准确性提高，将加速保险公司和医疗机构对产品的接受度。其次，供应链应实现多元化，并开发模组化设计，以便在不影响临床疗效的前提下进行组件替换。这有助于降低政策引发的成本衝击，并支持灵活的生产能力。

对基于三角测量的调查方法进行透明的解释，该方法结合了主要临床发现、二手文献检验和基于情境的供应链分析。

本执行摘要的研究整合采用了三角测量法，结合了与主要相关人员的对话、二手证据的整合以及基于情境的供应链分析。主要资讯来源包括对临床意见领袖、采购经理和产品开发经理的结构化访谈，以了解他们对产品可用性、临床优先事项和商业性限制的实际观点。二级资讯来源利用了同行评审的临床文献、监管指导文件和已发布的最佳实践，以检验有关临床表现的论断，并确保其符合当前的护理标准。

简洁结论总结了技术创新、价值链韧性和证据生成如何决定永续采用和价值创造。

总之，胃肠医疗设备产业的特点是技术快速进步、医疗服务模式转移，以及日益复杂的商业环境，后者强调主导创新和营运韧性。高清影像、机器人技术和新型止血技术正在重新定义诊断和治疗的可能性，而门诊服务的扩展和区域差异则要求制定量身定制的商业策略。 2025年的定价凸显了供应链柔软性和成本建模的战略重要性，不仅要考虑组件成本，还要考虑总落地成本。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：胃肠道医疗设备市场：依产品类型划分

  • 胶囊内视镜系统
  • 内视镜成像系统
    • 高解析度内视镜
    • 超细内视镜
    • 影像内视镜
  • 内视镜治疗设备
    • 膨胀的气球
    • 息肉切除装置
    • 支架
  • 止血装置
    • 夹子
    • 止血粉
    • 热固化装置

第九章：胃肠道医疗设备市场：依技术划分

  • 胶囊内视镜
  • 光学内视镜
    • 软式内视镜
    • 硬式内视镜
  • 机器人辅助内视镜
  • 超音波超音波
    • 线性超音波内视镜
    • 超音波

第十章：胃肠道医疗设备市场：依应用领域划分

  • 出血控制
    • 机械止血
    • 喷雾型止血剂
    • 热凝固
  • 诊断影像
    • 病灶可视化
    • 运动功能评估
  • 息肉检测
  • 狭窄区域的扩张

第十一章：胃肠道医疗设备市场：依最终用户划分

  • 门诊手术中心
  • 诊断中心
  • 医院
  • 专科诊所

第十二章：胃肠道医疗设备市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章：胃肠道医疗设备市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章：胃肠道医疗设备市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国胃肠道医疗设备市场

第十六章：中国胃肠医疗设备市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • Asahi Kasei Medical Co., Ltd.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Group Incorporated
  • Fujifilm Holdings Corporation
  • Getinge AB
  • Johnson & Johnson Services, Inc.
  • Karl Storz SE & Co. KG
  • Leo Medical Co.,Ltd.
  • Medtronic plc
  • Merit Medical Systems, Inc.
  • Micro-Tech（Nanjing）Co., Ltd.
  • Olympus Corporation
  • Ovesco Endoscopy AG
  • Pentax Medical by HOYA Corporation
  • Prion Medical BV
  • Richard Wolf GmbH
  • Siemens Healthineers AG
  • Smith+Nephew
  • STERIS Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • WL Gore & Associates, Inc.
Product Code: MRR-7949F05839D3

The Gastrointestinal Devices Market was valued at USD 8.76 billion in 2025 and is projected to grow to USD 9.39 billion in 2026, with a CAGR of 7.89%, reaching USD 14.91 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 8.76 billion
Estimated Year [2026] USD 9.39 billion
Forecast Year [2032] USD 14.91 billion
CAGR (%) 7.89%

Concise introduction framing clinical drivers, technological acceleration, and stakeholder priorities shaping the future of gastrointestinal device innovation

The gastrointestinal devices landscape sits at the confluence of clinical necessity, technological acceleration, and evolving care delivery models. Recent years have seen end-to-end advances in diagnostic imaging, therapeutic endoscopy, and hemostasis that together shift clinical decision making earlier and reduce invasive interventions. These trends are driven by rising demand for minimally invasive procedures, a growing emphasis on outpatient and ambulatory care, and the necessity for higher-resolution visualization to identify subtle mucosal lesions. In turn, device developers and clinical teams are experimenting with integrated platforms that couple superior optics, refined accessory tools, and software-enabled workflows to shorten procedure time and enhance therapeutic precision.

Against this backdrop, stakeholders from hospital systems to specialty clinics are prioritizing devices that demonstrably improve throughput, lower complications, and enable remote or hybrid care pathways. Policymakers and payers are also influencing adoption through updated reimbursement frameworks that favor value-based outcomes. Moreover, device manufacturers face an increasingly complex regulatory environment in which evidence generation and post-market surveillance carry heightened importance. Taken together, these dynamics set the stage for a highly competitive innovation cycle, where clinical efficacy, workflow compatibility, and economic value determine which technologies achieve scale and which remain niche solutions.

In-depth analysis of the transformative clinical, technological, and commercial shifts reshaping procedure locations, device adoption, and competitive dynamics

The gastrointestinal device landscape is undergoing transformative shifts that are altering clinical pathways and commercial models. Technologically, higher-definition imaging and miniaturized platforms are enabling lesion detection at earlier stages, thereby influencing diagnostic algorithms and therapeutic intent. Concurrently, the convergence of optics, robotics, and software analytics is producing new hybrid platforms that couple diagnostic clarity with precise intervention capabilities, shifting procedural volumes from inpatient to ambulatory settings.

Operationally, the migration toward outpatient and ambulatory surgical centers is reshaping purchasing priorities; providers prioritize disposables that reduce turnover time and capital equipment that delivers robust utilization metrics. Meanwhile, digital integration, including enhanced image management and procedural analytics, is enabling performance benchmarking and remote proctoring, which accelerate clinician adoption curves. Regulatory and reimbursement practice updates are further incentivizing devices that show clear outcomes and cost-efficiencies. In market terms, smaller fast-moving innovators are challenging incumbent suppliers by targeting unmet clinical niches with focused, evidence-backed solutions. As a result, the competitive landscape favors agility, clinical trial rigor, and scalable manufacturing strategies that can support rapid market entry and iterative device improvements.

Comprehensive examination of how the 2025 U.S. tariffs reshaped supply chains, sourcing strategies, and commercial planning across gastrointestinal device makers

The tariff environment introduced by the United States in 2025 has created headwinds across global supply chains for gastrointestinal device manufacturers, with layered effects on component sourcing, manufacturing strategies, and pricing approaches. Manufacturers with vertically integrated supply chains or domestic production capacity experienced relative insulation compared with those that rely heavily on imported subassemblies or finished devices. As a consequence, procurement teams have had to reassess supplier diversity and nearshoring opportunities to mitigate exposure to applied duties.

In practice, the cumulative tariff impact extended beyond direct cost increases, influencing contractual negotiations and lead-time planning. OEMs and contract manufacturers began to restructure agreements to shift risk or incorporate tariff clauses, while strategic buyers accelerated dual-sourcing strategies to preserve continuity. Furthermore, some firms responded by qualifying alternative suppliers from tariff-favored regions or by investing in modular design changes that allowed substitution of affected components without compromising clinical performance. Importantly, this period strengthened the business case for greater supply chain transparency and scenario planning, with commercial teams increasingly modeling total landed cost rather than unit price alone. Taken together, the tariff developments underscored the necessity for resilience-oriented procurement, flexible manufacturing footprints, and commercial strategies that anticipate policy volatility without undermining clinical adoption timelines.

Holistic segmentation insights explaining how product categories, clinical applications, end users, and technology choices drive differentiated adoption and positioning

Segmentation insight reveals that product diversity and functional specialization are central to commercialization strategies and clinical adoption pathways across the gastrointestinal space. When analyzed by product type, key device categories include capsule endoscopy systems, endoscopic imaging systems, endotherapy devices, and hemostasis devices. Within endoscopic imaging, the differentiated subcategories of high-definition endoscopes, ultrathin endoscopes, and video endoscopes each address distinct clinical use cases: enhanced mucosal visualization, access to anatomically narrow lumens, and integrated digital workflows respectively. Endotherapy devices display similar stratification, where dilation balloons serve structural interventions, polypectomy devices address lesion resection, and stents support luminal patency; the choice among these tools often depends on lesion characteristics and procedural intent. Hemostasis devices further stratify into clips, hemostatic powders, and thermal coagulation devices, each selected based on bleeding etiology, accessibility, and clinician preference.

From an application standpoint, devices are deployed across bleeding management, diagnostic imaging, polyp detection, and stricture dilation. Bleeding management itself breaks down into mechanical hemostasis, sprayable hemostats, and thermal coagulation modalities, with selection influenced by bleed source and procedural context. Diagnostic imaging applications include lesion visualization and motility assessment, reflecting a dual focus on structural and functional diagnostics. In terms of end users, the buyer landscape spans ambulatory surgical centers, diagnostic centers, hospitals, and specialty clinics, each with different purchasing cycles, capital constraints, and utilization expectations. Finally, the technology axis differentiates capsule endoscopy, optical endoscopy, robotic endoscopy, and ultrasound endoscopy. Optical systems further bifurcate into flexible and rigid endoscopes, while ultrasound endoscopy differentiates into linear and radial ultrasound endoscopes, reflecting divergent imaging geometries and clinical indications. Integrating these segmentation perspectives clarifies how product development, commercial positioning, and evidence generation must align to meet the heterogeneous needs of clinicians and care settings.

Strategic regional insights detailing how Americas, Europe, Middle East & Africa, and Asia-Pacific differences shape device adoption, evidence needs, and commercial approaches

Regional dynamics materially influence prioritization of clinical features, reimbursement levers, and go-to-market strategies for gastrointestinal devices. In the Americas, healthcare delivery trends emphasize outpatient shift, consolidation of health systems, and an appetite for devices that improve throughput while maintaining strong clinical evidence. This region commonly demonstrates rapid uptake of technologies that align with procedural efficiency and centralized purchasing mechanisms, but also expects robust post-market data and interoperable systems.

In Europe, Middle East & Africa, heterogeneity in regulatory frameworks and reimbursement pathways means market entry strategies must be highly localized. Western European markets often demand rigorous clinical validation and demonstrate steady adoption for high-definition imaging and integrated platforms, whereas some emerging markets in the region prioritize cost-effective disposables and modular solutions. In the Middle East and Africa, infrastructure constraints and import logistics drive preference for durable equipment, simplified maintenance, and flexible training support. Across Asia-Pacific, diverse healthcare delivery models range from highly advanced tertiary care centers that adopt leading-edge endoscopic robotics to rapidly growing ambulatory networks in urban centers seeking commercially viable, scalable devices. Procurement strategies here frequently balance accelerated adoption in metropolitan hubs against price sensitivity in broader geographies. Recognizing these regional distinctions enables manufacturers to tailor clinical evidence packages, service models, and commercial approaches in ways that respect local decision drivers and accelerate sustainable adoption.

Key corporate strategies and competitive behaviors revealing how platform leaders, agile innovators, and manufacturing partners shape market trajectories

Competitive dynamics in the gastrointestinal devices arena are defined by a mix of established platform providers, targeted innovators, and vertically integrated manufacturers. Leading firms typically invest in comprehensive clinical programs, rigorous post-market surveillance, and partnerships with healthcare systems to demonstrate value. These companies often leverage modular platforms that allow incremental upgrades, facilitating long-term installed-base monetization and recurring revenue from consumables and accessories.

At the same time, smaller specialist firms and start-ups drive innovation in narrow clinical niches by rapidly iterating on design and leveraging focused clinical trials to capture early adopters. Their agility enables experimentation with alternative business models, such as service-based offerings or bundled procedural pricing, which can accelerate penetration in ambulatory and diagnostic center settings. Contract manufacturing organizations and component specialists have also become strategic partners; they enable cost-effective scaling and help OEMs navigate tariff-induced supply chain shifts by offering distributed manufacturing footprints. Across this ecosystem, companies that align rigorous clinical evidence with clear economic arguments and strong training and service models tend to outperform peers. Strategic alliances, co-development arrangements, and targeted acquisitions remain common approaches to augment technology portfolios and accelerate access to complementary channels and geographies.

Practical and prioritized recommendations for manufacturers and providers to enhance adoption, resilience, and commercial differentiation across clinical settings

Industry leaders should prioritize a set of pragmatic actions to capture clinical, operational, and commercial value across the gastrointestinal device landscape. First, align product development with measurable clinical outcomes and workflow efficiency gains so that procurement committees can readily quantify value. Investing in real-world evidence generation that demonstrates reduced procedure time, lower complication rates, or improved diagnostic yields will accelerate payer and institutional acceptance. Second, diversify supply chains and develop modular designs that allow component substitution without clinical compromise; this will reduce exposure to policy-driven cost shocks and support flexible manufacturing.

Third, tailor go-to-market approaches by end-user segment and region, recognizing that hospitals, ambulatory surgical centers, diagnostic centers, and specialty clinics have different capital cycles and utilization expectations. Fourth, build robust training and service programs that reduce learning curves and ensure consistent clinical outcomes; remote proctoring and digital training modules can be cost-effective ways to scale education globally. Fifth, explore innovative commercial models such as outcome-linked pricing, refurbished equipment programs, and consumable subscription models to align incentives with volume and value. Finally, pursue targeted partnerships to complement internal capabilities-whether for imaging software, robotics, or advanced materials-so that product roadmaps can accelerate while mitigating integration risk. Collectively, these actions can improve adoption velocity and create defensible value propositions in a competitive marketplace.

Transparent description of the triangulated research methodology combining primary clinical insights, secondary literature validation, and scenario-based supply chain analysis

The research synthesis underpinning this executive summary employed a triangulated methodology that combined primary stakeholder engagements with secondary evidence synthesis and scenario-based supply chain analysis. Primary inputs included structured interviews with clinical opinion leaders, procurement executives, and product development leaders to capture frontline perspectives on usability, clinical priorities, and commercial constraints. Secondary sources comprised peer-reviewed clinical literature, regulatory guidance documents, and published procedural best practices to validate clinical performance claims and to ensure alignment with current standards of care.

To understand operational resilience, scenario modeling was conducted to evaluate supply chain disruption vectors and tariff impacts, assessing mitigation options such as supplier diversification and nearshoring. Data validation steps included cross-referencing clinician-reported preferences with device utilization trends and post-market safety bulletins. The methodological approach prioritized transparency in assumptions, documented data provenance, and iterative validation with domain experts to minimize bias. Where evidence gaps were identified, recommended data collection pathways are included to support future iterations of the analysis, such as focused clinical registries or payer claims modeling to better quantify downstream economic outcomes.

Concise conclusion summarizing how technological innovation, supply chain resilience, and evidence generation determine sustainable adoption and value creation

In conclusion, the gastrointestinal devices domain is characterized by rapid technological progress, shifting care delivery paradigms, and an increasingly complex commercial environment that rewards evidence-driven innovation and operational resilience. High-definition imaging, robotics, and novel hemostasis modalities are redefining diagnostic and therapeutic possibilities, while outpatient care growth and regional variations necessitate tailored commercial strategies. The 2025 tariffs highlighted the strategic importance of supply chain flexibility and cost modeling that account for total landed cost rather than component price alone.

Looking ahead, organizations that pair rigorous clinical validation with adaptable manufacturing and pragmatic go-to-market models will be best positioned to scale. Equally important is the ability to provide comprehensive training and service to ensure consistent outcomes across diverse clinical settings. Ultimately, success will hinge on aligning product performance with measurable clinical benefit and economic value, enabling stakeholders to adopt innovations that improve patient care while sustaining long-term commercial viability.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Gastrointestinal Devices Market, by Product Type

  • 8.1. Capsule Endoscopy Systems
  • 8.2. Endoscopic Imaging Systems
    • 8.2.1. High Definition Endoscopes
    • 8.2.2. Ultrathin Endoscopes
    • 8.2.3. Video Endoscopes
  • 8.3. Endotherapy Devices
    • 8.3.1. Dilation Balloons
    • 8.3.2. Polypectomy Devices
    • 8.3.3. Stents
  • 8.4. Hemostasis Devices
    • 8.4.1. Clips
    • 8.4.2. Hemostatic Powders
    • 8.4.3. Thermal Coagulation Devices

9. Gastrointestinal Devices Market, by Technology

  • 9.1. Capsule Endoscopy
  • 9.2. Optical Endoscopy
    • 9.2.1. Flexible Endoscopes
    • 9.2.2. Rigid Endoscopes
  • 9.3. Robotic Endoscopy
  • 9.4. Ultrasound Endoscopy
    • 9.4.1. Linear Ultrasound Endoscopes
    • 9.4.2. Radial Ultrasound Endoscopes

10. Gastrointestinal Devices Market, by Application

  • 10.1. Bleeding Management
    • 10.1.1. Mechanical Hemostasis
    • 10.1.2. Sprayable Hemostats
    • 10.1.3. Thermal Coagulation
  • 10.2. Diagnostic Imaging
    • 10.2.1. Lesion Visualization
    • 10.2.2. Motility Assessment
  • 10.3. Polyp Detection
  • 10.4. Stricture Dilation

11. Gastrointestinal Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Diagnostic Centers
  • 11.3. Hospitals
  • 11.4. Specialty Clinics

12. Gastrointestinal Devices Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Gastrointestinal Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Gastrointestinal Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Gastrointestinal Devices Market

16. China Gastrointestinal Devices Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Abbott Laboratories
  • 17.6. Asahi Kasei Medical Co., Ltd.
  • 17.7. Becton, Dickinson and Company
  • 17.8. Boston Scientific Corporation
  • 17.9. CONMED Corporation
  • 17.10. Cook Group Incorporated
  • 17.11. Fujifilm Holdings Corporation
  • 17.12. Getinge AB
  • 17.13. Johnson & Johnson Services, Inc.
  • 17.14. Karl Storz SE & Co. KG
  • 17.15. Leo Medical Co.,Ltd.
  • 17.16. Medtronic plc
  • 17.17. Merit Medical Systems, Inc.
  • 17.18. Micro-Tech (Nanjing) Co., Ltd.
  • 17.19. Olympus Corporation
  • 17.20. Ovesco Endoscopy AG
  • 17.21. Pentax Medical by HOYA Corporation
  • 17.22. Prion Medical BV
  • 17.23. Richard Wolf GmbH
  • 17.24. Siemens Healthineers AG
  • 17.25. Smith+Nephew
  • 17.26. STERIS Corporation
  • 17.27. Stryker Corporation
  • 17.28. Teleflex Incorporated
  • 17.29. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GASTROINTESTINAL DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL GASTROINTESTINAL DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HIGH DEFINITION ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRATHIN ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY VIDEO ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DILATION BALLOONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYPECTOMY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTATIC POWDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY CAPSULE ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY FLEXIBLE ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RIGID ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ROBOTIC ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LINEAR ULTRASOUND ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY RADIAL ULTRASOUND ENDOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MECHANICAL HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPRAYABLE HEMOSTATS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY THERMAL COAGULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY LESION VISUALIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY MOTILITY ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY POLYP DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY STRICTURE DILATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 225. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 230. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 232. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 233. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 235. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 236. GCC GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 261. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 264. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 266. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 267. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 268. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 269. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 271. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 272. G7 GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 276. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 277. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 278. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 280. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 281. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 283. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 284. NATO GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL GASTROINTESTINAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES GASTROINTESTINAL DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOSCOPIC IMAGING SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY HEMOSTASIS DEVICES, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY OPTICAL ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY ULTRASOUND ENDOSCOPY, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA GASTROINTESTINAL DEVICES MARKET SIZE, BY BLEEDING MANAGEMENT, 2018-2032 (USD MILLI